FrancophonIA/ELRC3.0 huggingface dataset:
English: Clopidogrel/Acetylsalicylic acid Mylan has no or negligible influence on the ability to drive and use machines.
Croatian: Klopidogrel/acetilsalicilatna kiselina Mylan ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Therefore, concomitant use of clopidogrel with boosted ART should be discouraged.
Croatian: Stoga se ne preporučuje istodobna primjena klopidogrela s pojačanim lijekovima ART.
English: Contains lactose and Allura Red AC. See leaflet for further information.
Croatian: Sadrži laktozu i boju Allura Red AC.
English: Jaundice (yellowing of skin and/or eyes); burning in stomach and/or oesophagus (gullet); severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes in taste or loss of taste of foods, inflammation of small vessels.
Croatian: Vrlo rijetke nuspojave (mogu se javiti u manje od 1 na 10 000 osoba): žutica (žuta boja kože i/ili očiju); žarenje u želucu i/ili jednjaku (ždrijelo); jaka bol u trbuhu s ili bez bolova u leđima; vrućica, teškoće pri disanju, ponekad povezane s kašljem, generalizirane alergijske reakcije (primjerice, opći osjećaj vrućine s iznenadnom općom nelagodom do nesvjestice); oticanje u ustima; mjehurići na koži; kožne alergijske reakcije; upala u usnoj šupljini (stomatitis); pad krvnoga tlaka; zbunjenost; halucinacije; bol u zglobovima; bol u mišićima; poremećaj okusa ili gubitak osjeta okusa hrane, upala malih krvnih žila.
English: • repaglinide, medicine to treat diabetes,
Croatian: • repaglinid, lijek za liječenje dijabetesa,
English: Hypoglycaemia*, gout* (see section 4.4)
Croatian: Poremećaji metabolizma i prehrane hipoglikemija*, giht* (vidjeti dio 4.4)
English: Musculo-skeletal bleeding (haemarthrosis), arthritis, arthralgia, myalgia
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva mišićno-koštano krvarenje (hemartroza), artritis, artralgija, mialgija
English: The safety of the concomitant administration of clopidogrel/acetylsalicylic acid with other thrombolytic agents has not been formally established and should be undertaken with caution (see section 4.4).
Croatian: Sigurnost istodobne primjene klopidogrela/acetilsalicilatne kiseline i trombolitičkih lijekova nije formalno utvrđena te treba biti provedena s oprezom (vidjeti dio 4.4).
English: Due to the presence of ASA, methotrexate used at doses higher than 20 mg/week should be used with caution with Clopidogrel/Acetylsalicylic acid Mylan as it can inhibit renal clearance of methotrexate, which may lead to bone marrow toxicity.
Croatian: Metotreksat primijenjen u dozi većoj od 20 mg tjedno, treba primjenjivati s oprezom, jer lijek Klopidogrel/acetilsalicilatna kiselina Mylan, zbog ASK u svome sastavu, može smanjiti bubrežni klirens metotreksata, što može dovesti do toksičnih učinaka na koštanu srž.
English: In patients concomitantly receiving nicorandil and NSAIDs including ASA and LAS, there is an increased risk for severe complications such as gastrointestinal ulceration, perforation and haemorrhage (see section 4.5).
Croatian: U bolesnika koji istodobno primaju nikorandil i NSAIL-ove uključujući ASK i LAS (lizinacetilsalicilatna kiselina), povećan je rizik od teških komplikacija poput gastrointestinalne ulceracije, perforacije i hemoragije (vidjeti dio 4.5).
English: In patients concomitantly receiving nicorandil and NSAIDs including ASA and LAS, there is an increased risk for severe complications such as gastrointestinal ulceration, perforation and haemorrhage (see section 4.4).
Croatian: U bolesnika koji istodobno primaju nikorandil i NSAIL-ove uključujući ASK i LAS (lizinacetilsalicilatna kiselina), povećan je rizik od teških komplikacija poput gastrointestinalne ulceracije, perforacije i hemoragije (vidjeti dio 4.4).
English: Hydrogenated castor oil Starch pregelatinized Stearic acid
Croatian: Ricinusovo ulje, hidrogenirano Škrob, preželatiniziran Stearatna kiselina
English: • omeprazole or esomeprazole, medicines to treat upset stomach,
Croatian: • omeprazol ili esomeprazol, lijekove za smanjenje želučanih tegoba,
English: Clopidogrel/Acetylsalicylic acid Mylan contains lactose.
Croatian: Pomoćne tvari Klopidogrel/acetilsalicilatna kiselina Mylan sadrži laktozu.
English: • if you suffer from severe kidney disease.
Croatian: • ako patite od teške bolesti bubrega,
English: There are no fertility data with clopidogrel/acetylsalicylic acid.
Croatian: Nema podataka o plodnosti tijekom uzimanja klopidogrel/acetilsalicilatne kiseline.
English: Patients were randomized to receive either prasugrel 5 or 10 mg/d (Days 0-14) (n=1306), or prasugrel 5 or 10 mg/d (Days 0-7) then de-escalated to clopidogrel 75 mg/d (Days 8-14) (n=1306), in combination with ASA (<100 mg/day).
Croatian: Bolesnici su bili randomizirani tako da primaju prasugrel u dozi od 5 ili 10 mg/dan (dan 0 - 14) (n=1306) ili prasugrel u dozi od 5 ili 10 mg/dan (dan 0 - 7) nakon čega su prebačeni na de-eskaliranu terapiju - klopidogrel u dozi od 75 mg/dan (dan 8 - 14) (n=1306) u kombinaciji s acetilsalicilatnom kiselinom (< 100 mg/dan).
English: Renal failure*, acute renal impairment (especially in patients with existing renal impairment, heart decompensation, nephritic syndrome, or concomitant treatment with diuretics) *, glomerulonephritis, blood creatinine increased
Croatian: Poremećaji bubrega i mokraćnog sustava hematurija zatajenje bubrega*, akutno oštećenje bubrežne funkcije (naročito u bolesnika s postojećim oštećenjem bubrega, srčanom dekompenzacijom, nefrotičkim sindromom, ili istodobnim liječenjem diureticima)*, glomerulonefritis, povišenje kreatinina u krvi
English: New cardiovascular events (primary endpoint) were prevented, with relative risk reductions of 22% (CI: 8.6, 33.4), 32% (CI: 12.8, 46.4), 4% (CI: -26.9, 26.7), 6% (CI: -33.5, 34.3) and 14% (CI: -31.6, 44.2), during the 0-1, 1-3, 3-6, 6-9 and 9-12-month study intervals, respectively.
Croatian: Novi kardiovaskularni događaji (primarni ishod) su spriječeni, sa smanjenjem relativnog rizika od 22% (CI: 8,6; 33,4), 32% (CI: 12,8; 46,4), 4% (CI:
English: In one study, when a single dose of ibuprofen 400 mg was taken within 8 hours before or within 30 minutes after immediate release aspirin dosing (81 mg), a decreased effect of ASA on the formation of thromboxane or platelet aggregation occurred.
Croatian: U jednom ispitivanju, u kojem je primijenjena jednokratna doza ibuprofena od 400 mg unutar 8 sati prije ili unutar 30 min nakon uzimanja ASK
English: oral anticoagulants, medicines used to reduce blood clotting, ASA or another non-steroidal anti-inflammatory medicine usually used to treat painful and/or inflammatory conditions of muscle or joints, heparin or any other injectable medicine used to reduce blood clotting, ticlopidine, other antiplatelet agents, a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or fluvoxamine), medicines usually used to treat depression,
Croatian: • lijekove koji mogu povećati rizik od krvarenja, na primjer: - oralne antikoagulanse, lijekove koji sprječavaju zgrušavanje krvi, - ASK ili druge nesteroidne protuupalne lijekove koji se obično koriste za liječenje bolnih i/ili upalnih stanja mišića ili zglobova, - heparin ili bilo koji drugi lijek koji se daje injekcijom za sprječavanje zgrušavanja krvi, - tiklopidin, drugi antitrombocitni lijek, - selektivne inhibitore ponovne pohrane serotonina (uključujući, ali ne ograničeno na fluoksetin ili fluvoksamin), lijekove koji se obično koriste za liječenje depresije,
English: Heparins were administered in more than 90% of the patients and the relative rate of bleeding between clopidogrel plus ASA and ASA alone was not significantly affected by the concomitant heparin therapy.
Croatian: Heparine je primalo više od 90% bolesnika, a na relativnu stopu krvarenja nije značajno utjecalo istodobno liječenje heparinom niti u skupini koja je primala klopidogrel plus ASK niti u onoj koja je primala ASK u monoterapiji.
English: Warnings and precautions If any of the situations mentioned below apply to you, you should tell your doctor before taking Clopidogrel/Acetylsalicylic acid Mylan:
Croatian: Ako se na Vas odnosi bilo koje od dolje navedenih stanja, morate obavijestiti liječnika prije nego što uzmete lijek Klopidogrel/acetilsalicilatna kiselina Mylan:
English: The concomitant administration of Clopidogrel/Acetylsalicylic acid Mylan with oral anticoagulants is not recommended since it may increase the intensity of bleeding (see section 4.4).
Croatian: Istodobna primjena lijeka Klopidogrel/acetilsalicilatna kiselina Mylan i drugih oralnih antikoagulansa se ne preporučuje, jer može povećati intenzitet krvarenja (vidjeti dio 4.4).
English: Tablet core: microcrystalline cellulose, lactose (see section 2 ‘Clopidogrel/Acetylsalicylic acid Mylan contains lactose'), croscarmellose sodium, hydroxypropylcellulose, colloidal anhydrous silica, talc, hydrogenated castor oil, pregelatinized starch, stearic acid, iron oxide yellow (E172).
Croatian: Jezgra tablete: mikrokristalična celuloza, laktoza (vidjeti dio 2. „Klopidogrel/acetilsalicilatna kiselina Mylan sadrži laktozu”), kroskarmeloza natrij, hidroksipropilceluloza, koloidni bezvodni silicijev dioksid, talk, hidrogenirano ricinusovo ulje, preželatinizirani škrob, stearatna kiselina, žuti željezov oksid (E172).
English: In particular, in a post-hoc analysis in 2,172 patients (17% of the total CURE population) who underwent stent placement (Stent-CURE), the data showed that clopidogrel compared to placebo, demonstrated a significant RRR of 26.2% favouring clopidogrel for the co-primary endpoint (CV death, MI, stroke) and also a significant RRR of 23.9% for the second co-primary endpoint (CV death, MI, stroke or refractory ischaemia).
Croatian: Rezultati tzv. post-hoc analize provedene na 2172 bolesnika (17% ukupne populacije ispitanika u CURE studiji) kojima je ugrađen stent (StentCURE), su pokazali da je klopidogrel u usporedbi s placebom, pokazao značajno smanjenje relativnog rizika (RRR) od 26,2% za koprimarni ishod (smrt zbog kardiovaskularnih uzroka, infarkt miokarda,
English: As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged (see sections 4.4 and 5.2).
Croatian: Kao mjera opreza, ne preporučuje se istodobna primjena lijekova koji su jaki ili umjereni inhibitori CYP2C19 (vidjeti dio 4.4 i 5.2).
English: Patients should be told about the signs and symptoms of GI undesirable effects and what steps to take if they occur.
Croatian: Bolesnicima treba objasniti znakove i simptome mogućih gastrointestinalnih nuspojava i što učiniti ako se pojave. (vidjeti dio 4.8).
English: Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy.
Croatian: Podaci iz epidemioloških ispitivanja upućuju da se, nakon primjene inhibitora sinteze prostaglandina u ranoj trudnoći, povećava rizik od pobačaja, srčanih malformacija i gastroshize.
English: Patients were randomised to clopidogrel (300 mg loading dose followed by 75 mg/day, N=6,259) plus ASA (75-325 mg once daily) or ASA alone (N=6,303), (75-325 mg once daily) and other standard therapies.
Croatian: Bolesnici su randomizirani u skupine koje su primale klopidogrel (udarna doza od 300 mg, a nakon toga 75 mg/dan, N=6259) plus ASK (75 mg do 325 mg jedanput dnevno) ili samu ASK (N=6303, 75 mg do 325 mg jedanput dnevno), uz drugu standardnu terapiju.
English: The most common side effect which has been seen with Clopidogrel/Acetylsalicylic acid Mylan is bleeding.
Croatian: Najčešća nuspojava lijeka Klopidogrel/acetilsalicilatna kiselina Mylan jest krvarenje.
English: Glycerol monocaprylocaprate (E422) Sodium lauril sulfate
Croatian: Glicerol monokaprilokaprat (E422)
English: Patients should also be told that it might take longer than usual to stop bleeding when they take Clopidogrel/Acetylsalicylic acid Mylan, and that they should report any unusual bleeding (site or duration) to their physician.
Croatian: Bolesnicima koji uzimaju lijek Klopidogrel/acetilsalicilatna kiselina Mylan potrebno je objasniti da će krvarenje možda trajati dulje nego obično te da moraju obavijestiti liječnika ako se pojavi bilo kakvo neočekivano krvarenje (mjesto i trajanje krvarenja).
English: Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, druginduced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus, fixed eruption*
Croatian: bulozni dermatitis (toksična epidermalna nekroliza, Stevens Johnsonov sindrom, erythema multiforme, akutna generalizirana egzantematozna pustuloza (AGEP)), angioedem, sindrom preosjetljivosti izazvane lijekom, kožni osip uzrokovan lijekom s eozinofilijom i sistemskim simptomima (engl.
English: • Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention
Croatian: u bolesnika s akutnim koronarnim sindromom bez elevacije ST-segmenta (nestabilna angina ili non-Q-infarkt miokarda), uključujući bolesnike kojima se ugrađuje stent nakon perkutane koronarne intervencije,
English: The concomitant administration of Clopidogrel/Acetylsalicylic acid Mylan with oral anticoagulants is not recommended since it may increase the intensity of bleeding (see section 4.5).
Croatian: Ne preporučuje se istodobna primjena lijeka Klopidogrel/acetilsalicilatna kiselina Mylan i drugih oralnih antikoagulansa, jer to može pojačati intenzitet krvarenja (vidjeti dio 4.5).
English: In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period.
Croatian: Nadalje, u životinja koje su tijekom perioda organogeneze primale inhibitore sinteze prostaglandina, prijavljena je veća učestalost različitih malformacija uključujući kardiovaskularne.
English: Therapeutic experience is limited in patients with moderate hepatic disease who may have bleeding diatheses (see section 4.4).
Croatian: Terapijsko iskustvo u bolesnika s umjerenim oštećenjem funkcije jetre koji bi mogli imati povećanu sklonost krvarenju je ograničeno (vidjeti dio 4.4).
English: The number of patients experiencing the co-primary endpoint (CV death, MI, stroke or refractory ischaemia) was 1,035 (16.5%) in the clopidogrel plus ASA group and 1,187 (18.8%) in the ASA group, a 14% relative risk reduction (95% CI of 6%-21%, p=0.0005) for the clopidogrel plus ASA group.
Croatian: U skupini koja je primala klopidogrel plus ASK bilo je 1035 (16,5%) bolesnika sa koprimarnim ishodom (smrt zbog kardiovaskularnih uzroka, infarkt miokarda, moždani udar ili refraktorna ishemija), odnosno 1187 (18,8%) bolesnika u skupini koja je primala samo ASK, što znači smanjenje relativnoga rizika od 14% (95% CI: 6% - 21%, p=0,0005) u skupini koja je primala klopidogrel plus ASK.
English: Therapeutic experience is limited in patients with mild to moderate renal impairment (see section 4.4).
Croatian: Terapijsko iskustvo u bolesnika s blagim do umjerenim oštećenjem funkcije bubrega je ograničeno (vidjeti dio 4.4).
English: Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly.
Croatian: Eksperimentalni podaci upućuju da, ako su primijenjeni istodobno, ibuprofen može inhibirati učinak niske doze acetilsalicilatne kiseline na agregaciju trombocita.
English: The primary outcome, a composite of cardiovascular death, stroke, urgent revascularization, and BARC (Bleeding Academic Research Consortium) bleeding ≥2 at 1 year post ACS, occurred in 43 patients (13.4%) in the de-escalated DAPT group and in 85 patients (26.3%) in the unchanged DAPT group (p<0.01).
Croatian: Bleeding Academic Research Consortium) stupnja krvarenja ≥ 2 u prvoj godini nakon akutnog koronarnog sindroma dogodio se u 43 bolesnika (13,4%) u skupini s de-eskaliranim DAPTom i u 85 bolesnika (26,3%) u skupini s nepromijenjenim DAPT-om (p<0,01).
English: Patients received clopidogrel (300 mg loading dose, followed by 75 mg/day, n=1,752) plus ASA or ASA alone (n=1,739), (150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin.
Croatian: Bolesnici su primali klopidogrel (prvo udarnu dozu od 300 mg, a nakon toga dozu od 75 mg na dan, N=1725) plus ASK ili samo ASK (N=1739, 150 mg do 325 mg kao udarnu dozu nakon čega je slijedila doza od 75 mg do 162 mg na dan) uz fibrinolitik i, po potrebi, heparin.
English: Valproic acid
Croatian: Valproatna kiselina
English: Uricosurics (benzbromarone, probenecid, sulfinpyrazone) Caution is required because ASA may inhibit the effect of uricosuric agents through competitive elimination of uric acid.
Croatian: Potreban je oprez jer ASK inhibira učinak urikozurika putem kompetitivne eliminacije mokraćne kiseline.
English: Croscarmellose sodium Hydroxypropylcellulose Colloidal anhydrous silica Talc
Croatian: Kroskarmeloza natrij Hidroksipropilceluloza Silicijev dioksid, koloidni, bezvodni Talk
English: NN:
Croatian: ASK:
English: From the beginning of the sixth month of pregnancy, all prostaglandin synthesis inhibitors may expose: the foetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;
Croatian: • fetus: - kardiopulmonalnoj toksičnosti (s preranim zatvaranjem duktusa arteriosusa i plućnom hipertenzijom); - bubrežnoj disfunkciji, koja se može razviti u bubrežno zatajenje sa oligohidroamnionom;
English: The ASA in Clopidogrel/Acetylsalicylic acid Mylan is rapidly hydrolysed in plasma to salicylic acid, with a half-life of 0.3 to 0.4 hours for ASA doses from 75 to 100 mg. Salicylic acid is primarily conjugated in the liver to form salicyluric acid, a phenolic glucuronide, an acyl glucuronide, and a number of minor metabolites.
Croatian: ASK u lijeku Klopidogrel/acetilsalicilatna kiselina Mylan brzo se u plazmi hidrolizira u salicilatnu kiselinu koja ima poluvijek od 0,3 do 0,4 sata za doze ASK od 75 do 100 mg.
English: ASA group, a 20% relative risk reduction (RRR) (95% CI of 10%-28%; p=0.00009) for the clopidogrel plus ASA group [17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG)].
Croatian: U skupini koja je primala klopidogrel plus ASK bilo je 582 (9,3%) bolesnika s primarnim ishodom (smrt zbog kardiovaskularnih uzroka, infarkt miokarda ili moždani udar), a u skupini koja je primala samo ASK 719 (11,4%) bolesnika, što je 20%-tno smanjenje relativnog rizika (95% CI; 10% - 28%; p=0,00009) u skupini koja se liječila klopidogrelom plus ASK [17% smanjenje relativnoga rizika u bolesnika koji su liječeni konzervativno, 29% u bolesnika podvrgnutih perkutanoj transluminalnoj koronarnoj angioplastici (PTCA) s ili bez ugradnje stenta i 10% u bolesnika podvrgnutih aortokoronarnom premoštenju (CABG)].
English: What you need to know before you take Clopidogrel/Acetylsalicylic acid Mylan Do not take Clopidogrel/Acetylsalicylic acid Mylan
Croatian: Što morate znati prije nego počnete uzimati lijek Klopidogrel/acetilsalicilatna kiselina Mylan
English: if you have any stomach or abdominal pain or bleeding in the stomach or bowels (red stools or black stools).
Croatian: • Obavijestite svog liječnika ako planirate kirurški zahvat (uključujući stomatološke zahvate), ako imate želučane ili abdominalne bolove ili krvarenje u želucu ili crijevima (crvena ili crna stolica).
English: The bottles contain a desiccant.
Croatian: U bocama se nalazi sredstvo za sušenje.
English: It is unknown whether ASA dose in Clopidogrel/Acetylsalicylic acid Mylan alters fertility.
Croatian: Nije poznato utječe li doza ASK u lijeku Klopidogrel/acetilsalicilatna kiselina Mylan na plodnost.
English: While you are taking Clopidogrel/Acetylsalicylic acid Mylan
Croatian: Dok uzimate lijek Klopidogrel/acetilsalicilatna kiselina Mylan
English: Patients should be counselled about the risks of gastrointestinal injury and bleeding while taking clopidogrel plus ASA with alcohol, especially if alcohol consumption is chronic or heavy.
Croatian: Bolesnike treba savjetovati o rizicima od gastrointestinalnog oštećenja i krvarenja ako konzumiraju alkohol tijekom liječenja klopidogrelom i ASK, osobito ako je konzumacija alkohola kronična ili obilna. (vidjeti dio 4.5).
English: Respiratory tract bleeding (haemoptysis, pulmonary haemorrhage), bronchospasm, interstitial pneumonitis, noncardiogenic pulmonary oedema with chronic use and in the context of a hypersensitivity reaction due to acetylsalicylic acid*, eosinophilic pneumonia.
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja epistaksa krvarenje u dišnom sustavu (hemoptiza, plućno krvarenje), bronhospazam, intersticijski pneumonitis, nekardiogeni edem pluća pri kroničnoj primjeni i u sklopu reakcije preosjetljivosti na acetilsalicilatnu kiselinu*, eozinofilna pneumonija
English: Although the administration of clopidogrel 75 mg/day did not modify the pharmacokinetics of S-warfarin or International Normalised Ratio (INR) in patients receiving long-term warfarin therapy, coadministration of clopidogrel with warfarin increases the risk of bleeding because of independent effects on haemostasis.
Croatian: International Normalised Ratio) u bolesnika koji primaju dugotrajnu terapiju varfarinom, istodobna primjena klopidogrela s varfarinom povećava rizik od krvarenja zbog nezavisnih učinaka na hemostazu.
English: HDPE bottles with white opaque polypropylene screw cap with aluminium induction sealing liner wad and desiccant containing 100 film-coated tablets.
Croatian: 100 filmom obloženih tableta u boci od polietilena visoke gustoće (HDPE) s bijelim neprozirnim polipropilenskim navojnim zatvaračem s aluminijskom zaštitnom folijom i sredstvom za sušenje.
English: Appropriate therapy should be considered if bleedings are observed.
Croatian: Ako se primijeti krvarenje, treba odmah odrediti primjerenu terapiju.
English: Hearing loss* or tinnitus*
Croatian: Poremećaji uha i labirinta vrtoglavica gubitak sluha* ili tinitus*
English: Therefore Clopidogrel/Acetylsalicylic acid Mylan should be used with caution in these patients.
Croatian: Stoga, u tih bolesnika, lijek Klopidogrel/acetilsalicilatna kiselina Mylan treba primjenjivati s oprezom.
English: • nicorandil, medicine to treat cardiac chest pain.
Croatian: • nikorandil, lijek za liječenje boli u prsnom košu uzrokovane problemima sa srcem,
English: Haemodialysis is the preferred treatment for severe intoxication.
Croatian: Preporučeni postupak za liječenje teške intoksikacije je hemodijaliza.
English: How to store Clopidogrel/Acetylsalicylic acid Mylan
Croatian: Kako uzimati lijek Klopidogrel/acetilsalicilatna kiselina Mylan
English: Clopidogrel/Acetylsalicylic acid Mylan must not be used in patients with severe hepatic impairment (see section 4.3).
Croatian: Klopidogrel/acetilsalicilatna kiselina Mylan ne smije se primjenjivati u bolesnika s teškim oštećenjem funkcije jetre (vidjeti dio 4.3).
English: GI undesirable effects including stomach pain, heartburn, nausea, vomiting, and GI bleeding may occur.
Croatian: Nuspojave u gastrointestinalnom sustavu uključuju bol u trbuhu, žgaravicu, mučninu, povraćanje, a može se pojaviti i gastrointestinalno krvarenje.
English: BOTTLE LABEL
Croatian: BOCA (NALJEPNICA)